{Etokimab: A Deep Investigation into the 2022981-44-6 Antibody Etokimab, designated by the distinct identifier 2022981-44-6, represents a emerging antibody currently subject to therapeutic evaluation. This medicinal https://www.targetmol.com/compound/etokimab